During the past decade, International Diabetes Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 19 clinical trials were completed, i.e. on average, 79.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 7 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Diabetes Center" #1 sponsor was "HealthPartners Institute" with 23 trials, followed by "Medtronic Diabetes" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Insulet Corporation" with 4 trials sponsored and "Mannkind Corporation" with 4 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Diabetes Center" #1 collaborator was "International Diabetes Center at Park Nicollet" with 16 trials as a collaborator, "Abbott Diabetes Care" with 6 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Jaeb Center for Health Research" with 4 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 4 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "International Diabetes Center" are "Type 2 Diabetes" (13 trials), "Type 1 Diabetes" (8 trials), "Diabetes" (7 trials), "Type 1 Diabetes Mellitus" (7 trials) and "Diabetes Mellitus, Type 2" (6 trials). Many other conditions were trialed in "International Diabetes Center" in a lesser frequency.

Most popular intervention types in "International Diabetes Center" are "Device" (29 trials), "Drug" (15 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (3 trials), "Omnipod Horizon™ Automated Glucose Control System" (3 trials), "CGM System for Type 1 and Type 2 Diabetes Mellitus" (2 trials), "Continuous Glucose Monitor" (2 trials) and "Insulin aspart" (2 trials). Other intervention names were less common.

The vast majority of trials in "International Diabetes Center" are 60 trials for "All" genders.

Currently, there are NaN active trials in "International Diabetes Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 47 completed trials in International Diabetes Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in International Diabetes Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 27 trials that are defined as “Not Applicable".